SBI Healthcare Opportunities Fund Direct Growth
Add To Comparepreviously known as SBI Pharma Dir Gr until
NAV on September 16, 2026
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
₹5,796 cr
Turnover Ratio
26.45%
Expense Ratio
1.02%
Exit Load
0.50%
if redeemed within
Returns
- 1M: Negative return: -1.38%
- 1Y: Positive return: 19.19%
- 3M: Positive return: 9.70%
- 3Y: Positive return: 23.51%
- 6M: Positive return: 24.28%
- 5Y: Positive return: 17.70%
Other plans of SBI Healthcare Opportunities